PharmAla Biotech announced that it has signed on to act as exclusive supplier of both GMP LaNeo™ MDMA and Engineering MDMA to InterVivo Solutions (Toronto), its client companies and Affiliates. InterVivo Solutions is a well-established pre-clinical contract research organization (CRO) with expertise in neuropsychiatric and neurological diseases. Together with Transpharmation, they form the largest boutique neuroscience-specialized in vivo CRO.
Through this agreement, PharmAla will provide both its GMP, clinical-grade LaNeo™ MDMA to InterVivo and its client companies, as well as engineering MDMA for animal research. The agreement allows for simple access to MDMA for research purposes for all of InterVivo's clients at reduced prices, and guarantees access to MDMA that can be taken all the way from pre-clinical to clinical, human research.